Budesonide Delayed Release Capsules 1
Budesonide Capsule, Delayed Release
Product Images NDC 65162-778
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 65162-778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Budesonide Delayed Release Capsules 2
This is a description of a medication with the NDC code of 65162-778-30. It is a delayed-release capsule that contains 3mg of Budesonide, which is a type of medication used to treat asthma and Crohn's disease. It is recommended to take 3 of these capsules every morning and to refer to the package insert for further instructions. The capsules should be stored at room temperature, between 20°C to 25°C, and in a tight container. This medication is for prescription use only and distributed by Amneal Pharmaceuticals LLC.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
